• Home
  • Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.

Author List
Smith CC, Wang Q, Chin CS, Salerno S, Damon LE, Levis MJ, Perl AE, Travers KJ, Wang S, Hunt JP, Zarrinkar PP, Schadt EE, Kasarskis A, Kuriyan J, Shah NP
Publication
Nature
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1161864
Publication Year
2012
PubMed ID
22504184
Publication Title
Smith CC, Wang Q, Chin CS, Salerno S, Damon LE, Levis MJ, Perl AE, Travers KJ, Wang S, Hunt JP, Zarrinkar PP, Schadt EE, Kasarskis A, Kuriyan J, Shah NP. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. Nature. 2012 Apr 15; 485(7397):260-3.